Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06015750
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-11
First Post:
2023-08-23
Brief Title:
Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa STRENSIQ for Hypophosphatasia
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc